Security National Bank of Sioux City Iowa IA Boosts Holdings in Thermo Fisher Scientific Inc. $TMO

Security National Bank of Sioux City Iowa IA raised its stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 25.1% in the second quarter, according to its most recent 13F filing with the SEC. The fund owned 7,783 shares of the medical research company’s stock after buying an additional 1,560 shares during the period. Thermo Fisher Scientific comprises about 1.6% of Security National Bank of Sioux City Iowa IA’s portfolio, making the stock its 16th largest holding. Security National Bank of Sioux City Iowa IA’s holdings in Thermo Fisher Scientific were worth $3,902,000 as of its most recent filing with the SEC.

Several other hedge funds have also bought and sold shares of TMO. Anchor Investment Management LLC boosted its stake in shares of Thermo Fisher Scientific by 31.2% during the 2nd quarter. Anchor Investment Management LLC now owns 8,232 shares of the medical research company’s stock worth $4,127,000 after acquiring an additional 1,960 shares in the last quarter. ABS Direct Equity Fund LLC purchased a new position in Thermo Fisher Scientific in the 2nd quarter valued at $251,000. Rench Wealth Management Inc. raised its holdings in Thermo Fisher Scientific by 17.6% in the 2nd quarter. Rench Wealth Management Inc. now owns 2,906 shares of the medical research company’s stock valued at $1,457,000 after acquiring an additional 434 shares during the last quarter. Bouchey Financial Group Ltd. purchased a new position in Thermo Fisher Scientific during the second quarter worth approximately $205,000. Finally, Van Hulzen Asset Management LLC purchased a new stake in Thermo Fisher Scientific in the 2nd quarter valued at $260,000. Hedge funds and other institutional investors own 89.23% of the company’s stock.

Thermo Fisher Scientific Stock Performance

TMO stock traded down $7.50 on Friday, hitting $650.82. The company’s stock had a trading volume of 4,579,493 shares, compared to its average volume of 2,260,237. Thermo Fisher Scientific Inc. has a 1 year low of $435.27 and a 1 year high of $663.57. The company has a current ratio of 1.55, a quick ratio of 1.18 and a debt-to-equity ratio of 0.74. The stock has a market cap of $240.64 billion, a price-to-earnings ratio of 35.01, a price-to-earnings-growth ratio of 2.71 and a beta of 0.85. The firm has a 50 day moving average of $590.31 and a two-hundred day moving average of $522.03.

Thermo Fisher Scientific (NYSE:TMO) last announced its earnings results on Thursday, July 23rd. The medical research company reported $6.03 EPS for the quarter, beating analysts’ consensus estimates of $5.71 by $0.32. The business had revenue of $11.99 billion during the quarter, compared to analysts’ expectations of $11.71 billion. Thermo Fisher Scientific had a net margin of 15.04% and a return on equity of 17.09%. The business’s revenue was up 10.5% compared to the same quarter last year. During the same period in the prior year, the company earned $4.28 earnings per share. Thermo Fisher Scientific has set its FY 2026 guidance at 24.930-25.330 EPS. Equities analysts predict that Thermo Fisher Scientific Inc. will post 25.13 EPS for the current fiscal year.

Thermo Fisher Scientific Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Investors of record on Tuesday, September 15th will be given a $0.47 dividend. This represents a $1.88 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date is Tuesday, September 15th. Thermo Fisher Scientific’s dividend payout ratio (DPR) is 10.11%.

Insider Activity at Thermo Fisher Scientific

In other news, VP Lisa Britt sold 11,440 shares of Thermo Fisher Scientific stock in a transaction dated Wednesday, August 19th. The shares were sold at an average price of $613.12, for a total value of $7,014,092.80. Following the sale, the vice president owned 14,784 shares of the company’s stock, valued at $9,064,366.08. The trade was a 43.62% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Michael Shafer sold 25,500 shares of the stock in a transaction dated Tuesday, August 11th. The stock was sold at an average price of $600.00, for a total transaction of $15,300,000.00. Following the transaction, the executive vice president directly owned 20,994 shares of the company’s stock, valued at $12,596,400. This represents a 54.85% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 73,768 shares of company stock worth $44,122,820 in the last 90 days. Corporate insiders own 0.33% of the company’s stock.

Analyst Ratings Changes

Several research firms have recently weighed in on TMO. Wells Fargo & Company cut shares of Thermo Fisher Scientific from an “overweight” rating to an “underweight” rating in a research note on Wednesday, September 9th. CLSA initiated coverage on shares of Thermo Fisher Scientific in a research report on Thursday, September 3rd. They set an “outperform” rating and a C$748.00 price target on the stock. Barclays boosted their target price on Thermo Fisher Scientific from $625.00 to $650.00 and gave the stock an “overweight” rating in a research note on Friday, July 24th. UBS Group upgraded shares of Thermo Fisher Scientific from a “neutral” rating to a “buy” rating and raised their price objective for the company from $540.00 to $730.00 in a report on Tuesday, September 8th. Finally, Wall Street Zen downgraded Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a report on Saturday, September 12th. Two investment analysts have rated the stock with a Strong Buy rating, seventeen have issued a Buy rating, five have given a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat.com, Thermo Fisher Scientific currently has an average rating of “Moderate Buy” and an average price target of $624.64.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc is a global supplier of scientific equipment, laboratory services and analytical technologies. The company serves pharmaceutical and biotechnology companies, clinical laboratories, academic and government institutions, industrial businesses and other research organizations.

Its products and services include laboratory instruments, analytical systems, reagents, consumables, software and related services. Thermo Fisher also provides laboratory supplies and equipment, bioproduction solutions, genetic analysis technologies, clinical diagnostics, specialty diagnostic products and contract research and manufacturing services through its laboratory services businesses.

The company was formed in 2006 through the merger of Thermo Electron Corporation and Fisher Scientific International.